Live Breaking News & Updates on Zhifei Lvzhu Biopharma

Stay updated with breaking news from Zhifei lvzhu biopharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Week In Review: OrbiMed Plans To Raise $1.1 Billion For Fifth Asia Fund

OrbiMed Asia V plans to raise $1.1 billion, OrbiMed Flagship IX seeks $1.9 billion and OrbiMed Royalty & Credit Opportunities $1.75 billion. ....

United States , Zhifei Lvzhu Biopharma , Kintor Pharma , Newsoara Biopharma , Nikang Pharma , Coherus Bio , Taicang San Diego , Junshi Biosciences , Hansoh Pharma , Orbimed Asia , Shanghai Jemincare Pharmaceuticals , Orion Corporation , Orbimed Flagship , Orbimed Royalty , Greater China , Jemincare Pharmaceuticals , Shanghai Junshi Biosciences , China Phase , Palisade Bio , Hepatocellular Carcinoma , Inmagene Biopharmaceuticals ,